Back to Search Start Over

FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS

Authors :
Li, Jieni
Chikermane, Soumya G.
Earla, Jagadeswara R.
Hutton, George J.
Aparasu, Rajender R.
Source :
Multiple Sclerosis and Related Disorders; 20220101, Issue: Preprints
Publication Year :
2022

Abstract

:Since the introduction of oral disease-modifying agents (DMA) in 2010, the treatment options for multiple sclerosis (MS) have changed significantly. There is limited information regarding the factors associated with switching to oral DMA among prevalent injectable DMA users.

Details

Language :
English
ISSN :
22110348
Issue :
Preprints
Database :
Supplemental Index
Journal :
Multiple Sclerosis and Related Disorders
Publication Type :
Periodical
Accession number :
ejs59051735
Full Text :
https://doi.org/10.1016/j.msard.2022.103703